In the HR− primary tumors, HER2-positive tumors had lower Ki67 scores than HER2-low and HER2-zero tumors, which indicated triple-negative breast cancer (TNBC) (Fig. 1B and Table 1). This evidence concerns the gene MKI67 and triple-negative breast carcinoma.